In 1998, Sehgal et al. first found CXCR4 was overexpressed in glioblastoma cell lines, and the expression of antisense CXCR4 inhibited glioma cell proliferation (Sehgal et al., 1998). The gene discussed is CXCR4; the disease is glioblastoma.